A recent survey by the Travel Health Insurance Association of Canada (THiA) found that one fifth of Canadians planning a vacation this year are unaware of the implications of travelling with cannabis. Furthermore, 22% of survey respondents with medical cannabis prescriptions said that now the drug is legal, they can pack medical cannabis products in their carry-ons just like other prescription drugs, regardless of where they’re travelling to.

One of the most traded companies on the TSX, Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) announced on Thursday that it had completed the open market sale of recent spin-off Australis Capital Inc. (CSE:AUSA) common shares on behalf of non-Canadian residents.

A total of 11,222,349 common shares in Australis Capital were disposed of in the public markets by the designated broker.

Australis Capital is a new investment vehicle that span off from Aurora Cannabis in September this year and it has a special focus on growth opportunities in the U.S. cannabis industry. The company has since moved its headquarters from Canada to Las Vegas, Nevada.

Canadians eat or smoke anywhere between 400 to 1,600 tonnes of cannabis per year, according to a few months of sewage samples examined for the federal government.

The wide-ranging estimate, released by Statistics Canada on Thursday, is the first look at cannabis use through a new technique called wastewater-based epidemiology. The tests involve gauging traces of THC, the active ingredient in marijuana, at 15 wastewater treatment plants in five different cities, including Vancouver.

After cannabis is metabolized in the body, traces of THC are left behind in human waste. Scientists collected wastewater on the second week of each month from March to August this year – before cannabis was legalized in Canada on Oct. 17.

Operational efficiency is a key aspect of any successful business, and especially so in an industry such as cannabis where superior supply chains are a critical competitive advantage.

Operational efficiencies translate into higher productivity – higher revenues and margins – with your asset base.

One common ratio used to measure efficiency is the asset turnover ratio, which measures how many dollars of revenue a company generates with a single dollar of assets. Companies generating higher revenues per dollar of assets have a greater probability of also generating higher returns for shareholders. Today, we’ve weeded out three Canadian cannabis stocks with notable efficiencies as demonstrated by their asset turnover ratios.

The Sault Ste. Marie Police Service now has its first two Drager DrugTest 5000 drug testing devices for use in roadside checks of drivers suspected of being under the influence of marijuana or cocaine.

The units consist of a large bag containing mouth swab kits (necessary for drug impairment tests, in contrast to breathalyzer units used to test for suspected alcohol impairment), the Drager DrugTest 5000 device itself, an attached keyboard and a small printer.

Consolidation in the cannabis industry is expected to continue and the recent pullback in the stock prices of marijuana companies has investors wondering which pot stocks might be the best buys to play a potential takeover premium.

Let’s take a look at HEXO (TSX:HEXO) to see if it deserves to be on your buyout radar.

Const. Derek Gallamore was shocked when his department in Delta, B.C., busted a woman allegedly selling weed-laced brownies with 40 times the recommended single dose of THC.

The sugary treat looked identical to a regular grocery store confection but packed a whopping 400 milligrams of THC, the psychoactive ingredient in marijuana. He immediately imagined what might happen if a toddler came across the dessert.

"Being a parent, I looked at it and went, 'Wait a second.' " he said. "There were no warning labels for children."

Though cannabis was legalized Oct. 17, edibles will not be legal until sometime within the next year. But that hasn't stopped entrepreneurs from cooking up pot-infused candies, cookies and other items and selling them online or in dispensaries.

Marijuana, long sneaked on to college and university campuses for use in bongs and joints, is now being grown legally at several academic institutions across the country.

Eight academic institutions have obtained licences from Health Canada to cultivate cannabis for scientific purposes, allowing them to closely study the drug that was legalized for recreational use in October.

Some received special licences a few months before legalization and will be moving to licences with fewer restrictions in the future. The University of Guelph is one of them.

Max Jones, an assistant professor in the department of agriculture, received cannabis plants several weeks ago after the school was granted a license in September.

Kristen Yoder doesn’t want to crush your entrepreneurial dreams — but she will if she has to. Never one to offer a useless Pollyanna pat on the back, she’d rather deliver hard truths to clients right away and get to the business of viability.

Sam and Leyla Butero, residents of Yucaipa, California, can attest to that fact after hiring Yoder to advise them on a potential cannabis business they had in mind. “There are plenty of people out there who will take your money and tell you what you want to hear,” says Leyla. “What I like about Kristen is that she’ll tell you exactly what she thinks. She’ll tell you what can and cannot be done.”

Cannabis stocks have been getting some bad press lately. Between legalization problems, growing losses and increasing short positions, producers are beginning to feel the heat. Critics have claimed that weed producers are focused too much on generating PR and too little on generating income. In part, the criticisms have been justified.

Cannabis stocks had always been the subject of much hype, and the industry’s leaders played no small part in cultivating it. Now, with supply chain issues damaging the industry’s goodwill, some are saying the hype-driven bubble has burst.

But that doesn’t mean there aren’t some good cannabis picks out there.